Monday, May 4, 2015

Deals

Electrovaya’s Acquisition Of Evonik Litarion GmbH Complete

May 3, 2015 · Leave a Comment 

  The noted Canadian lithium-ion battery developer/manufacturer Electrovaya has completed its acquisition of Evonik Litarion GmbH — along with completing the licensing process for the “SEPARION” ceramic composite separator — according to a recent press release. The completion of the process means that Evonik Litarion’s automated lithium-ion electrode + ceramic composite separator production plant — with a rated production capacity of half a gigawatt-hour (GWh) of electrodes, and 10 million m2 of ceramic separators — is now under the control of Electrovaya. Accompanying this... [Read the full story]

Deal News

Electrovaya’s Acquisition Of Evonik Litarion GmbH Complete

May 3, 2015 · Leave a Comment 

  The noted Canadian lithium-ion battery developer/manufacturer Electrovaya has completed its acquisition of Evonik Litarion GmbH — along with completing the licensing process for the “SEPARION” ceramic composite separator — according to a recent press release. The completion of the process means that Evonik Litarion’s automated lithium-ion electrode + ceramic composite separator production plant — with a rated production capacity of half a gigawatt-hour (GWh) of electrodes, and 10 million m2 of ceramic separators — is now under the control of Electrovaya. Accompanying this... [Read the full story]

Legal

Semafone and Eckoh agree to settlement

March 19, 2015 · Leave a Comment 

  Guildford, Surrey, 19th March 2015 – Eckoh plc and Semafone® have agreed to a confidential settlement of their dispute over alleged infringement and invalidity of Semafone’s UK Patent (No. GB 2,473,376), to the mutual benefit of both parties.  Under the settlement, Semafone has granted a worldwide licence to their granted patents, trademarks and patent applications covering certain dual tone multi-frequency (“DTMF”) masking methods of taking secure payments over the phone, for the benefit of Eckoh, its customers and suppliers. In consideration of the licence, Eckoh... [Read the full story]

Bio

R-Tech Ueno buys commercialization rights from Santen Pharma

April 30, 2015 · Leave a Comment 

  R-Tech Ueno, Ltd, engaged in the research, development, manufacture, and sale of pharmaceutical products for the treatment of ophthalmology and dermatology worldwide, has acquired the right to develop and commercialize DE-105 from Santen Pharmaceutical Company, Ltd. DE-105 is a treatment targeting at persistent corneal epithelial defects that Santen has been developing. By acquisition of this right, R-Tech Ueno undertakes development of this agent towards commercialisation going forward. “Moreover, we have also concluded an agreement with the inventor of DE-105, Professor Emeritus Teruo... [Read the full story]

University Tech Transfer

Anivax Licenses UA-Developed Poultry Vaccine

May 2, 2015 · Leave a Comment 

  Anivax and the University of Arizona have announced an agreement to license several technologies developed in a broad-based collaborative effort between the UA and Arizona State University. The license is for a revolutionary Campylobacter food safety vaccine designed to be administered to poultry to reduce colonization by the bacteria and ultimately lower the incidence of human disease and associated conditions. The team of inventors includes individuals from both institutions, including: Bibiana Law, associate research professor in the UA School of Animal and Comparative Biomedical Sciences,... [Read the full story]

People

IP Industry: we start here

March 8, 2015 · Leave a Comment 

In 2007, we set out to change the world of intellectual property, and how innovation and ideas were exchanged among IP owners and those that desired IP. We knew there were significant headwinds with an entrenched, decades-old ecosystem of long held beliefs about the “way things ought to be done” and who were we to come along and try to change things. None of this did anything to deter us; it drove us even harder. Not to gloat or brag, but many of the world’s LARGEST IP Owners and Transactors are now our customers- more on that in later posts.  They see the same future. IP Attorneys said... [Read the full story]

Deals

Electrovaya’s Acquisition Of Evonik Litarion GmbH Complete

  The noted Canadian lithium-ion battery developer/manufacturer Electrovaya has completed its acquisition of Evonik Litarion GmbH — along with completing the licensing process for the “SEPARION” ceramic composite separator — according to a recent press release. The completion of the process means that Evonik Litarion’s automated lithium-ion... Read more of this article


Yaskawa Motoman licenses ultrasonic technology

  Yaskawa Motoman, a global robotics manufacturer headquartered in Miamisburg, has entered into a multi-year license agreement with Nihon Shoryoku Co. Ltd., company officials announced. Under terms of the agreement, Yaskawa Motoman will have exclusive rights in the Americas for the technology, manufacturing and sales of NSK’s ultrasonic cutting... Read more of this article


SDI Signs Strategic Technology License & Supply Agreement

  Florida, Tampa – Security Devices International Inc. (“SDI” or “the Company”) today announced the signing of a five-year, non-exclusive, renewable Technology License and Supply Agreement (“TLSA”) with United Tactical Solutions (“UTS”) of Chicago, IL. UTS is a global provider of specialized... Read more of this article


World Patent Marketing China Signs A Licensing Agreement

  SHANGHAI, China, May 1, 2015 (GLOBE NEWSWIRE) — via PRWEB – World Patent Marketing, a vertically integrated manufacturer and distributor of patented products, is pleased to announce that it has successfully negotiated a licensing deal for a Kansas inventor. The manufacturer is none other than World Patent Marketing China, World Patent... Read more of this article


Anivax Licenses UA-Developed Poultry Vaccine

  Anivax and the University of Arizona have announced an agreement to license several technologies developed in a broad-based collaborative effort between the UA and Arizona State University. The license is for a revolutionary Campylobacter food safety vaccine designed to be administered to poultry to reduce colonization by the bacteria and ultimately... Read more of this article


Spark acquires rights to license Clearside’s technology

  Spark Therapeutics, Inc., a gene therapy leader,  and Clearside Biomedical, Inc., a clinical-stage biopharmaceutical company, have entered into an option agreement under which Spark acquired exclusive rights to license Clearside’s microinjector technology to deliver gene therapies to the back of the eye. Under the agreement, the companies... Read more of this article


Bellicum Pharmaceuticals Licenses TCR Technology From Leiden University Medical Center

  Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies, today announced it has entered into a license agreement with Leiden University Medical Center (LUMC), Netherlands, for worldwide rights to develop, manufacture and commercialize high-affinity... Read more of this article


R-Tech Ueno buys commercialization rights from Santen Pharma

  R-Tech Ueno, Ltd, engaged in the research, development, manufacture, and sale of pharmaceutical products for the treatment of ophthalmology and dermatology worldwide, has acquired the right to develop and commercialize DE-105 from Santen Pharmaceutical Company, Ltd. DE-105 is a treatment targeting at persistent corneal epithelial defects that... Read more of this article


BRUSA Elektronik AG Licenses WiTricity Patent Portfolio

  WATERTOWN, Mass.–(BUSINESS WIRE)–WiTricity, the industry pioneer in wireless power transfer over distance, today announced an intellectual property licensing agreement with BRUSA Elektronik AG, a leading global supplier of advanced power electronics for electrified vehicles. Under the terms of the agreement, BRUSA will license WiTricity’s... Read more of this article


Spark Therapeutics and Clearside Biomedical Option to License Technology

  PHILADELPHIA, April 28, 2015 /PRNewswire/ — Spark Therapeutics, Inc. ONCE, +9.56% and Clearside Biomedical, Inc. announced today that they have entered into an option agreement under which Spark acquired exclusive rights to license Clearside’s microinjector technology to deliver gene therapies to the back of the eye. Under the... Read more of this article


More Posts From Deals

Legal

Semafone and Eckoh agree to settlement

  Guildford, Surrey, 19th March 2015 – Eckoh plc and Semafone® have agreed... 


Iteris, Wavetronix Settle Patent Infringement Litigation

  SANTA ANA, Calif.–Iteris, Inc. (NYSE MKT: ITI), a leader in providing... 


More Posts From Legal

University Tech Transfer

Anivax Licenses UA-Developed Poultry Vaccine

  Anivax and the University of Arizona have announced an agreement to license... 


Bellicum Pharmaceuticals Licenses TCR Technology From Leiden University Medical Center

  Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a clinical stage biopharmaceutical... 


More Posts From University Tech Transfer